The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.
PLoS pathogens
View this publicationPLoS pathogens
View this publicationThe New England journal of medicine
View this publicationCell reports
View this publicationScience (New York, N.Y.)
View this publicationScience (New York, N.Y.)
View this publicationRheumatology (Oxford, England)
View this publicationPLoS pathogens
View this publicationNature immunology
View this publicationeLife
View this publicationThe Journal of physiology
View this publication